iKang Healthcare Group, Inc.
KANG
KANG was delisted on the 18th of January, 2019.
67 hedge funds and large institutions have $564M invested in iKang Healthcare Group, Inc. in 2015 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 20 closing their positions.
960% more call options, than puts
Call options by funds: $27.7M | Put options by funds: $2.61M
40% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 20
26% more capital invested
Capital invested by funds: $447M → $564M (+$117M)
21% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 14
10% more funds holding
Funds holding: 61 → 67 (+6)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sculptor Capital
New York
|
+$32.1M |
| 2 |
HSBC Holdings
London,
United Kingdom
|
+$14.7M |
| 3 |
Citigroup
New York
|
+$7.29M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$4.67M |
| 5 |
First Manhattan
New York
|
+$4.48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$29.8M |
| 2 |
JC
Joho Capital
New York
|
-$19.1M |
| 3 |
MAM
Myriad Asset Management
North Point,
Hong Kong
|
-$15.1M |
| 4 |
FI
Fosun International
Hong Kong,
China
|
-$11.7M |
| 5 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
-$10.3M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MYAM
76
Meiji Yasuda Asset Management
Tokyo,
Japan
| – | -$1.46M | -98,400 | Closed |
|
|
RFC
77
Russell Frank Company
Seattle,
Washington
| – | -$1.11M | -75,802 | Closed |
|
|
BAMS
78
Bellevue Asset Management (Switzerland)
Kuesnacht,
Switzerland
| – | -$1.11M | -75,000 | Closed |
|
79
Artisan Partners
Milwaukee,
Wisconsin
| – | -$736K | -49,754 | Closed |
|
80
Fidelity Investments
Boston,
Massachusetts
| – | -$610K | -41,200 | Closed |
|
|
LP
81
LMR Partners
London,
United Kingdom
| – | -$596K | -40,240 | Closed |
|
|
TI
82
Trexquant Investment
Stamford,
Connecticut
| – | -$583K | -39,400 | Closed |
|
|
AG
83
Aperio Group
Sausalito,
California
| – | -$153K | -10,312 | Closed |
|
|
CCP
84
Clough Capital Partners
Boston,
Massachusetts
| – | -$141K | -9,500 | Closed |
|
|
RIM
85
RS Investment Management
San Francisco,
California
| – | -$125K | -8,428 | Closed |
|
86
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$70 | -4,701 | Closed |
|
87
Creative Planning
Overland Park,
Kansas
| – | -$30K | -2,000 | Closed |
|
KANG Hedge Fund Activity: Q4 2015 in Review
67 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in iKang Healthcare Group, Inc. (KANG) for Q4 2015, worth a combined $564M — up 26% from $447M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new KANG positions and 20 closed out — a net gain of 8 holders — while 17 added to existing stakes and 14 trimmed.
The largest buyer was Sculptor Capital, adding an estimated $32.1M. The largest seller was JP Morgan Chase, cutting an estimated $29.8M.
- 67 institutional investors held iKang Healthcare Group, Inc. (KANG) as of Q4 2015, up from 61 in Q3 2015.
- Funds reported $564M of iKang Healthcare Group, Inc. stock for Q4 2015, up 26% quarter-over-quarter.
- 28 funds opened new iKang Healthcare Group, Inc. positions in Q4 2015 and 20 closed out, a net change of +8 holders.
- The largest iKang Healthcare Group, Inc. buyer in Q4 2015 was Sculptor Capital, an estimated $32.1M added.
- The largest iKang Healthcare Group, Inc. seller in Q4 2015 was JP Morgan Chase, an estimated $29.8M sold.
Based on aggregated 13F filings for Q4 2015.